To determine whether the activity of the NLRP3 inflammasome was altered in atrial tissue of patients with CKD, we evaluated the levels of key proteins of the NLRP3 inflammasome pathway in a second cohort of patients undergoing open-heart surgery for coronary bypass grafting and/or valve replacement. The gene discussed is NLRP3; the disease is chronic kidney disease.